Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Innofactor's Lumagate trial concluded

By Frans-Mikael RostedtAnalyst
Innofactor

Translation: Original comment published in Finnish on 07/04/2024 at 7:17 am EEST

Innofactor announced that the arbitration tribunal has awarded the case for the benefit of the defendant in the Lumagate acquisition. As a result, Innfoactor will not receive the previously awarded damages of 2.3 MEUR in full. The company’s distribution share shall be around 1.0 MEUR at the maximum.  In addition, Innofactor will bear its own trial costs of approximately EUR 309,000, the opposing party’s costs of approximately EUR 310,000 and the costs for the arbitration, EUR 166,150.  In other words, the total expenses amount to approximately EUR 785,000. We believe that Innofactor will receive at least 5 MSEK (EUR ~441,000) from the bankruptcy estate. In our forecasts, we had previously estimated that the net amount received by Innofactor would be zero. Based on the announcement, it is difficult to estimate how much Innofactor could eventually receive from the bankruptcy estate, but as a whole, the release is not very dramatic relative to our forecasts.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team